Medication info
Donegreen Tablets 10 mg (Donepezil Hydrochloride Monohydrate)

Donegreen Tablets 10 mg (Donepezil Hydrochloride Monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Donepezil Hydrochloride Hydrate›10mg / 1 tablet
Manufacturer / importer
Sears Pharmaceutical Co., Ltd.
Appearance
Yellow round film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201902849 · Approved 2019.05.02 · Insurance code 689000710

Summary

Main use
Treatment of symptoms of Alzheimer's-type dementia
Who takes it
Adults · Children
Adult dose
○ Adults : Administer donepezil hydrochloride 5 mg once daily at bedtime. If sleep disturbances such as unusual dreams, nightmares, or insomnia occur, morning administration of this medicine may be considered. Since donepezil concentrations reach steady state 15 days after administration and the incidence of adverse reactions may be affected by the rate of dose escalation, administer the 5 mg dose for 4~6 weeks. After assessing the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg per day, administer with caution regarding gastrointestinal adverse reactions. If treatment with this medicine is discontinued, its effects gradually diminish, and no rebound effect occurs with abrupt discontinuation. ○ Female patients aged 85 years and older with low body weight : Because adverse reactions occur more frequently, careful monitoring is required. Elderly female patients with low body weight should not receive more than 5 mg per day.
Child dose
○ Pediatrics : There is no experience with use in children.

Ingredients

Manufacturer
Sears Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of symptoms of Alzheimer's-type dementia

  • Symptoms of Alzheimer's disease
View approved original text

This medication is used for the treatment of symptoms associated with Alzheimer's disease.

How to take

Adult dose

○ Adults : Administer donepezil hydrochloride 5 mg once daily at bedtime. If sleep disturbances such as unusual dreams, nightmares, or insomnia occur, morning administration of this medicine may be considered. Since donepezil concentrations reach steady state 15 days after administration and the incidence of adverse reactions may be affected by the rate of dose escalation, administer the 5 mg dose for 4~6 weeks. After assessing the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg per day, administer with caution regarding gastrointestinal adverse reactions. If treatment with this medicine is discontinued, its effects gradually diminish, and no rebound effect occurs with abrupt discontinuation. ○ Female patients aged 85 years and older with low body weight : Because adverse reactions occur more frequently, careful monitoring is required. Elderly female patients with low body weight should not receive more than 5 mg per day.

Child dose

○ Pediatrics : There is no experience with use in children.

Precautions

This medicine contains Donepezil Hydrochloride Monohydrate as its active ingredient and is used for the treatment of symptoms associated with Alzheimer's disease. Firstly, this medication should not be administered to certain patients. For instance, individuals allergic to this medicine or its components, pregnant women, or women who may become pregnant, and nursing mothers should not take this medicine. Moreover, patients with lactose intolerance or specific genetic metabolic disorders should also avoid this medicine. Patients with heart disease or cardiac conduction abnormalities should use this medication cautiously as it may slow heart rate or cause arrhythmias. Additionally, patients with peptic ulcers or currently using non-steroidal anti-inflammatory drugs should be cautious as gastrointestinal symptoms may worsen. Patients with a history of asthma or obstructive pulmonary disease should also proceed with caution when taking this medication, as symptoms may worsen. Care should be taken for those with extrapyramidal disorders, such as Parkinson's disease, as symptoms may deteriorate with this drug. This medication contains the pigment Yellow No. 5, requiring caution from patients allergic to this component. Reported side effects while taking this medication include dizziness, nausea, vomiting, diarrhea, fatigue, headache, loss of appetite, insomnia, hallucinations, bradycardia, heart block, liver dysfunction, cerebrovascular abnormalities, and muscular issues. In severe cases, there is a risk of fainting, cardiac arrest, acute pancreatitis, and acute renal failure, and any emerging symptoms should prompt immediate consultation with healthcare professionals. This medication is approved for use only in patients with Alzheimer's disease and should not be used for other forms of dementia or memory disorders. Treatment should be conducted under the supervision of an experienced physician, with periodic evaluations of the patient's condition determining whether to continue therapy. Caution is necessary while driving or operating machinery as this medication may impair these abilities, particularly during initial use or after dose adjustments. This medication can interact with several drugs; therefore, it is essential to inform healthcare professionals if taken concomitantly with cardiac medications, antibiotics, antidepressants, antipsychotics, or anti-inflammatory pain relievers. Pregnant or nursing women are generally advised against using this medication, and if unavoidable, careful decisions must be made in consultation with specialists. The safety of this medication in children has not been established, and it is not to be used in pediatric patients. In the case of overdose, symptoms may include nausea, vomiting, bradycardia, respiratory depression, and convulsions, requiring immediate medical attention. Atropine may be used as an antidote in cases of overdose. Lastly, this medication should be kept out of reach of children, and changing the storage container is not advisable for maintaining quality.

Side effects

  • Syncope
  • bradycardia
  • heart block
  • QT interval prolongation
  • myocardial infarction
  • heart failure
  • peptic ulcer
  • perforated duodenal perforation
  • gastrointestinal bleeding
  • hepatitis
Show 226 more
  • liver dysfunction
  • jaundice
  • cerebral seizures
  • cerebral hemorrhage
  • cerebrovascular disorders
  • motor dysfunction
  • ataxia
  • movement disorders
  • dystonia
  • tremors
  • involuntary movements
  • gait disorders
  • abnormal postures
  • speech disorders
  • akinetic mutism
  • extreme muscle rigidity
  • dysphagia
  • tachycardia
  • blood pressure fluctuations
  • sweating
  • myalgia
  • weakness
  • dyspnea
  • acute pancreatitis
  • acute renal failure
  • unexplained sudden death
  • cold
  • loss of appetite
  • hallucinations
  • excitement
  • aggressive behavior
  • anxiety disorders
  • insomnia
  • drowsiness
  • increased libido
  • talkativeness
  • mania
  • nightmares
  • nervousness
  • gibberish
  • delusions
  • depression
  • confusion
  • indifference
  • hyperactivity
  • increased libido
  • hypersexuality
  • dizziness
  • tremors
  • seizures
  • confusion
  • thoracic rigidity
  • palpitations
  • sinoatrial block
  • atrioventricular block
  • hypertension
  • hypotension
  • atrial fibrillation
  • torsades de pointes
  • QT interval prolongation on ECG
  • diarrhea
  • nausea
  • vomiting
  • abdominal disorders
  • gastric and duodenal ulcers
  • constipation
  • salivation
  • fecal incontinence
  • liver dysfunction including hepatitis
  • rash
  • itching
  • muscle cramps
  • myalgia
  • urinary incontinence
  • frequent urination
  • urinary retention
  • headache
  • fatigue
  • pain
  • toothache
  • facial flushing
  • malaise
  • asthenia
  • edema
  • fever
  • decreased body temperature
  • decreased hematocrit
  • leukopenia
  • anemia
  • thrombocytopenia
  • falls
  • eczema
  • urinary incontinence
  • abdominal pain
  • weakness
  • fungal infection
  • influenza-like syndrome
  • allergies
  • soft tissue infection
  • malaise
  • sepsis
  • facial edema
  • hernia
  • hypotension
  • bradycardia
  • abnormal ECG
  • heart failure
  • myocardial infarction
  • angina
  • atrial fibrillation
  • congestive heart failure
  • peripheral vascular disease
  • supraventricular ectopic beats
  • ventricular ectopic beats
  • cardiac hypertrophy
  • constipation
  • gastroenteritis
  • fecal incontinence
  • dyspepsia
  • increased γ-GT
  • gastritis
  • dysphagia
  • periodontitis
  • gastric ulcer
  • periodontal abscess
  • abdominal distention
  • liver dysfunction
  • belching
  • esophagitis
  • anal bleeding
  • diabetes
  • anemia
  • leukocytosis
  • weight loss
  • peripheral edema
  • edema
  • increased LDH
  • increased alkaline phosphatase
  • hypercholesterolemia
  • hypokalemia
  • hypoglycemia
  • weight gain
  • hyperbilirubinemia
  • increased BUN
  • B12 deficiency anemia
  • cachexia
  • increased creatinine
  • gout
  • hyponatremia
  • hypoalbuminemia
  • iron deficiency anemia
  • increased AST
  • increased ALT
  • arthritis
  • arthrosis
  • bone fracture
  • arthralgia
  • leg cramps
  • osteoporosis
  • myalgia
  • restlessness
  • anxiety
  • tremors
  • convulsions
  • psychotic disorders
  • gait abnormalities
  • apathy
  • delusions
  • dream abnormalities
  • cerebrovascular abnormalities
  • increased salivation
  • ataxia
  • euphoric state
  • vasodilation
  • cerebral hemorrhage
  • cerebral infarction
  • cerebral ischemia
  • dementia
  • extrapyramidal symptoms
  • generalized tonic-clonic seizures
  • hemiplegia
  • hypertonia
  • hypokinesia
  • pharyngitis
  • pneumonia
  • increased cough
  • bronchitis
  • dyspnea
  • rhinitis
  • asthma
  • rash
  • skin ulcer
  • itching
  • psoriasis
  • skin discoloration
  • herpes zoster
  • dry skin
  • sweating
  • urticaria
  • vesicular rash
  • conjunctivitis
  • glaucoma
  • visual disturbances
  • ear pain
  • lacrimation abnormalities
  • urinary tract infections
  • cystitis
  • hematuria
  • diabetes
  • vaginitis
  • urinary disorders
  • frequent urination
  • proteinuria
  • abdominal pain
  • restlessness
  • cholecystitis
  • confusion
  • convulsions
  • hallucinations
  • heart block
  • hemolytic anemia
  • hepatitis
  • hyponatremia
  • neuroleptic malignant syndrome
  • pancreatitis
  • rash

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in a tightly closed container that is not exposed to air, and it is best kept at room temperature between 1 to 30 degrees Celsius. This storage method helps maintain the effectiveness of the medicine and prevents degradation.

Appearance and packaging

Appearance

Yellow round film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.